欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/1720/001
药品名称Finomel Perifer
活性成分
    • alanine 20.7 g/l
    • arginine 11.5 g/l
    • CALCIUMCHLORID dihydrate 0.74 g/l
    • fish oil, rich in omega 3-acids 40.0 g/l
    • glucose 130.0 g/l
    • glycine 10.3 g/l
    • histidine 4.8 g/l
    • isoleucine 6.0 g/l
    • leucine 7.3 g/l
    • lysine 5.8 g/l
    • MAGNESIUMSULFAT 2.47 g/l
    • medium-chain triglycerides 50.0 g/l
    • methionine 4.0 g/l
    • olive oil 50.0 g/l
    • phenylalanine 5.6 g/l
    • potassium chloride acetate 4.48 g/l
    • proline 6.8 g/l
    • serine 5.0 g/l
    • sodium acetate 5.62 g/l
    • sodium glycerophosphate hydrate 5.92 g/l
    • soybean oil 60.0 g/l
    • threonine 4.2 g/l
    • tryptophan 1.8 g/l
    • tyrosine 0.4 g/l
    • valine 5.8 g/l
    • zinc sulfate 0.02 g/l
剂型Emulsion for infusion
上市许可持有人Baxter Medical AB Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Greece (GR)
    • Norway (NO)
      Finomel Perifer
    • Finland (FI)
    • Poland (PL)
      Finomel Peri
    • Czechia (CZ)
      FINOMEL, infuzní emulze
    • Germany (DE)
      Finomel
    • Netherlands (NL)
      Finomel Peri, Finomel
    • Luxembourg (LU)
      Periomegomel, Emulsion pour perfusion
    • Iceland (IS)
      Finomel Perifer innrennslislyf, fleyti
    • United Kingdom (Northern Ireland) (XI)
    • Belgium (BE)
      Periomegomel émulsion pour perfusion
    • Denmark (DK)
    • Italy (IT)
    • Spain (ES)
    • France (FR)
    • Austria (AT)
      Finomel Peri Emulsion zur Infusion
    • Ireland (IE)
许可日期2018/11/28
最近更新日期2024/08/28
药物ATC编码
    • B05BA10 combinations
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase